Financial Statements

Abbott Laboratories (ABT)

$113.98

+0.21 (+0.18%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2021 2020 2019 2018 2017
Retained Earnings (Previous Year) 27,62725,84724,56023,978-
Net Income 7,0714,4953,6872,368477
Stock Dividends 32-155-13018825,350
Dividend Paid -3,202-2,560-2,270-1,974-1,849
Retained Earnings 31,52827,62725,84724,56023,978

PPE Schedule

Year 2021 2020 2019 2018 2017
Gross PPE 9,0298,0387,5637,607-
Annual Depreciation 1,8153,1682,1131,3508,742
Capital Expenditure -1,885-2,177-1,638-1,394-1,135
Net PPE 8,9599,0298,0387,5637,607

Intangible and Goodwill Schedule

Year 2021 2020 2019 2018 2017
Intangible and Goodwill (Previous Year) -24,02023,25423,19523,744
New Purchases -210-131-103-83-173
Intangible and Goodwill 24,02023,25423,19523,74423,231

Abbott Laboratories income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Abbott Laboratories FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.